tm logo
TALRAMZY
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 29 Nov 2023

Last Applicant/ Owned by

One Johnson & Johnson Plaza

New Brunswick

NJ

08933

Serial Number

97176339 filed on 16th Dec 2021

Registration Number

N/A

Correspondent Address

Cheryl L. Foytlin

JOHNSON & JOHNSON

ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK,NJ 08933

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

TALRAMZY

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcersRead More

Classification Information


Class [005]
Pharmaceutical Products


Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Mark Details


Serial Number

No 97176339

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T46510US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Nov 2023SOU TEAS EXTENSION RECEIVED
29th Nov 2023SOU EXTENSION 2 FILED
29th Nov 2023SOU EXTENSION 2 GRANTED
27th May 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25th May 2023SOU TEAS EXTENSION RECEIVED
25th May 2023SOU EXTENSION 1 FILED
25th May 2023SOU EXTENSION 1 GRANTED
13th Feb 2023ASSIGNED TO EXAMINER
27th Dec 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT